Webinar
RWE/RWD Studies: Top 3 Key Compliance Consideration
calendar

May 9, 2023

Calendar
clock

12:00pm - 1:00pm

GMT-04:00

Register

View all IQVIA events

In an unregulated space, RWE/RWD studies are not governed by the compliance standard GCP. RWD studies can provide enriching evidence towards the efficacy and safety of marketed medicines and medical devices, however, standardization surrounding the design and execution of noninterventional clinical studies is yet to be identified.

Learning objectives:

  1. Understand the expanded roles and responsibilities in the RWE setting
  2. Leverage existing GCP principles and practices in the design of a compliant framework for RWE/RWD studies
  3. Identify compliance risks and opportunities for QA/QC activities

 

Speaker:

Jan Pierre
Principal (GCP), Quality Compliance Solutions, IQVIA

Related solutions

Contact Us